Epirus Biopharmaceuticals

Epirus Biopharmaceuticals

closed
Expert insights on pharmaceuticals and health supplements to enhance mental and physical well-being. Learn more

Launch date
Employees
Market cap
€14.3k
Enterprise valuation
(€5m) (Public information from May 2024)
Massachusetts United States (HQ)
Authorizing premium user...